| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11550 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-34586-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26681-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-54572-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47859-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11462 | |||
![Immunohistochemistry-Paraffin: CD99 Antibody (MIC2/1495R) [NBP2-54373] - Formalin-fixed, paraffin-embedded human Ewing’s Sarcoma stained with CD99 Recombinant Rabbit Monoclonal Antibody (MIC2/1495R).](http://images.novusbio.com/fullsize/CD99-Antibody-MIC2-1495R-Immunohistochemistry-Paraffin-NBP2-54373-img0001.jpg "Immunohistochemistry-Paraffin: CD99 Antibody (MIC2/1495R) [NBP2-54373] - Formalin-fixed, paraffin-embedded human Ewing’s Sarcoma stained with CD99 Recombinant Rabbit Monoclonal Antibody (MIC2/1495R).")
![Immunohistochemistry-Paraffin: CD44 Antibody (SPM521) - IHC-Prediluted [NBP2-48407] - Human Breast Carcinoma stained with CD44 Monoclonal Antibody (SPM521)](http://images.novusbio.com/fullsize/CD44-Antibody-SPM521-IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-48407-img0002.jpg "Immunohistochemistry-Paraffin: CD44 Antibody (SPM521) - IHC-Prediluted [NBP2-48407] - Human Breast Carcinoma stained with CD44 Monoclonal Antibody (SPM521)")
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (C66/261) - IHC-Prediluted [NBP2-44899] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (C66/261).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-C66-261-IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-44899-img0003.jpg "Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (C66/261) - IHC-Prediluted [NBP2-44899] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (C66/261).")
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (C66/261) - IHC-Prediluted [NBP2-44899] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (C66/261).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-C66-261-IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-44899-img0002.jpg)
![Immunohistochemistry: CD44 Antibody (4B7) [NBP3-26681] - Image of CD44 Antibody (4B7) diluted at 1:100 and staining in paraffin-embedded human tonsil tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.](http://images.novusbio.com/fullsize/nbp3-26681_rabbit-cd44-mab-4b7-27220248203910.jpg "Immunohistochemistry: CD44 Antibody (4B7) [NBP3-26681] - Image of CD44 Antibody (4B7) diluted at 1:100 and staining in paraffin-embedded human tonsil tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.")
![Western Blot: CD44 Antibody (4B7) [NBP3-26681] - Positive Western Blot detected in Hela whole cell lysate, HepG2 whole cell lysate, A549 whole cell lysate. All lanes: CD44 Antibody at 1.25ug/ml. Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 82 KDa Observed band size: 82 KDa](http://images.novusbio.com/fullsize/nbp3-26681_rabbit-cd44-mab-4b7-2822024114098.jpg)
![Immunoprecipitation: RNF5 Antibody [NBP2-04014] - Samples: Whole cell lysate from 293T (15 and 50 ug for WB; 1 mg for IP, 20% of IP loaded), HeLa (H; 50 ug) and Jurkat (J; 50 ug) cells. Antibodies: Affinity purified rabbit anti-RNF5 antibody NBP2-04014 used for WB at 0.4 ug/ml (A) and 1 ug/ml (B) and used for IP at 6 ug/mg lysate. RNF5 was also immunoprecipitated by rabbit anti-RNF5 antibody, which recognizes a downstream epitope. Detection: Chemiluminescence with exposure times of 10 seconds (A) and 3 seconds (B).](http://images.novusbio.com/fullsize/RNF5-Antibody-Immunoprecipitation-NBP2-04014-img0001.jpg "Immunoprecipitation: RNF5 Antibody [NBP2-04014] - Samples: Whole cell lysate from 293T (15 and 50 ug for WB; 1 mg for IP, 20% of IP loaded), HeLa (H; 50 ug) and Jurkat (J; 50 ug) cells. Antibodies: Affinity purified rabbit anti-RNF5 antibody NBP2-04014 used for WB at 0.4 ug/ml (A) and 1 ug/ml (B) and used for IP at 6 ug/mg lysate. RNF5 was also immunoprecipitated by rabbit anti-RNF5 antibody, which recognizes a downstream epitope. Detection: Chemiluminescence with exposure times of 10 seconds (A) and 3 seconds (B).")
![Western Blot: RNF5 Antibody [NBP2-04014] - Whole cell lysate (50 µg) from K-562, Hep-G2, RKO,LNCaP, and HeLa cells prepared using NETN lysis buffer.Antibody: Affinity purified rabbit anti-RNF5 antibody used for WB at 0.4 µg/ml. Detection:Chemiluminescence with an exposure time of 30 seconds](http://images.novusbio.com/fullsize/antibody/nbp2-04014_rabbit-polyclonal-rnf5-antibody-western-blot-2112025115245..png)
![Immunohistochemistry-Paraffin: CD44 Antibody (CD44v6/1246) - variant 6 [NBP2-53203] - Formalin-fixed, paraffin-embedded human Tongue Carcinoma stained with CD44 Antibody (CD44v6/1246) - variant 6](http://images.novusbio.com/fullsize/CD44-Antibody-CD44v6-1246-variant-6-Immunohistochemistry-Paraffin-NBP2-53203-img0004.jpg "Immunohistochemistry-Paraffin: CD44 Antibody (CD44v6/1246) - variant 6 [NBP2-53203] - Formalin-fixed, paraffin-embedded human Tongue Carcinoma stained with CD44 Antibody (CD44v6/1246) - variant 6")
![Immunohistochemistry-Paraffin: CD44 Antibody (CD44v6/1246) - variant 6 [NBP2-53203] - Formalin-paraffin human Cervical Carcinoma stained with CD44v6 Monoclonal Antibody (CD44v6/1246)](http://images.novusbio.com/fullsize/CD44-Antibody-CD44v6-1246-variant-6-Immunohistochemistry-Paraffin-NBP2-53203-img0001.jpg)
![Flow Cytometry: CD37 Antibody (IPO-24) [NBP2-44750] - Flow Cytometric staining of PHA stimulated PBMC. Green isotype control; Red CD37 Antibody (IPO-24). Goat anti-Mouse PE was used as secondary antibody](http://images.novusbio.com/fullsize/CD37-Antibody-IPO-24-Flow-Cytometry-NBP2-44750-img0002.jpg "Flow Cytometry: CD37 Antibody (IPO-24) [NBP2-44750] - Flow Cytometric staining of PHA stimulated PBMC. Green isotype control; Red CD37 Antibody (IPO-24). Goat anti-Mouse PE was used as secondary antibody")